Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
- Citation:
- J Clin Oncol vol 39 (22) 2486-96
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- 10
- Parents:
- 3075
- Children:
- None
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, UG1CA233180, UG1CA233290, P30CA008748, UG1CA233234, UG1CA233324, UG1CA233327, UG1CA233331, UG1CA233339, UG1CA189819, UG1CA189858, U10CA180820 (ECOG-ACRIN), U10CA180819 (SWOG)
- Corr. Author:
- Authors:
- Jonathan E. Rosenberg Karla A. Ballman Susan Halabi Pamela J. Atherton Amir Mortazavi Christopher Sweeney Walter M. Stadler Benjamin A. Teply Joel Picus Scott T. Tagawa Sreedhar Katragadda Daniel Vaena Jamal Misleh Christopher Hoimes Elizabeth R. Plimack Thomas W. Flaig Robert Dreicer Dean Bajorin Olwen Hahn Eric J. Small Michael J. Morris
- Networks:
- CA136, CHRISTIANA, IA018, LAPS-CO070, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC010, LAPS-NY016, LAPS-OH007, NE003, NY018, SCOR, VA009
- Study
- CALGB-90601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: